Do you suffer from psoriasis?

We are looking for participants to join a clinical trial that will investigate the efficacy and safety of a new medicine called HRO350 in patients with mild to moderate psoriasis.

You may be able to take part in the study if you are over 18 years of age and have been diagnosed with mild to moderate plaque psoriasis.

Taking part in the study includes 8 visits to the study clinic. The study medicine HRO350 and the study related procedures are free of charge and you will be able to claim your travel costs for the study visits.

If you would like more information, please contact: Research Team on 01745 333647 and quote the ‘HeROPA’ study.

Are you a care giver with someone with Motor Neurone Disease?

See link below on how to take part in the study:

CLICK HERE

A new study exploring the effectiveness of a long Covid intervention is looking for people living with the condition to take part.

The Long COVID Personalised Self-management support co-design and Evaluation (LISTEN) study will evaluate the effectiveness of a new personalised support programme, co-designed by people living with long Covid.

Participants will be randomly selected into two groups, one receiving the LISTEN support package, which will involve a resource book and up to six, one-to-one video or telephone call support sessions, with the other group receiving their usual local NHS services.

The study is open to anyone over 18 years of age who has been experiencing long Covid symptoms for 12 weeks or more and has consulted with their GP. 

The LISTEN study is now open for recruitment. Please visit www.listentrial.co.uk for more information and to register your interest in taking part.

COVID-19 antiviral and antibody treatments

 Some people are now eligible to receive antiviral and antibody treatments for NHS patients at greater risk from severe COVID-19.

 There are 2 ways in which you can receive antiviral treatments:

 • as part of your standard care if you are at highest risk of severe COVID-19 and extremely vulnerable

• through a UK wide antiviral study called PANORAMIC available to COVID-19 positive patients over 50 or 18-49 with underlying health conditions

 Antivirals will be used alongside the vaccine, which still remains our most effective tool.

 To find out whether you are eligible for COVID-19 treatments or participation in a UK-wide antiviral study visit https://gov.wales/covid-19-treatments

A new research study for melanoma patients is now available online. Please follow the link below for further information:

My Melanoma Study - English 

My Melanoma Study - Welsh